000 | 01390 a2200421 4500 | ||
---|---|---|---|
005 | 20250518030804.0 | ||
264 | 0 | _c20200114 | |
008 | 202001s 0 0 eng d | ||
022 | _a1529-8019 | ||
024 | 7 |
_a10.1111/dth.12875 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHong, Joo R | |
245 | 0 | 0 |
_aRisk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice. _h[electronic resource] |
260 |
_bDermatologic therapy _c05 2019 |
||
300 |
_ae12875 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aLee, Yang W | |
700 | 1 | _aChoe, Yong B | |
700 | 1 | _aAhn, Kyu J | |
773 | 0 |
_tDermatologic therapy _gvol. 32 _gno. 3 _gp. e12875 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/dth.12875 _zAvailable from publisher's website |
999 |
_c29489859 _d29489859 |